CASP1 and chronic obstructive pulmonary disease: Various studies have shown that activation of the NLRP3/caspase-1 pathway contributes to the inflammatory response through the onset of diseases such as airway inflammation and chronic obstructive pulmonary disease including pulmonary fibrosis [44].